Increased proliferation of myoblasts after cyclic plasma perfusion of tumor-bearing rabbits

Japanese Journal of Cancer Research

Volumn 89, Issue 5, 1998, Pages 578-582

  Nakata, Shin Ichi ^a,b   Ishiko, Osamu ^a   Honda, Ken Ichi ^a   Hirai, Kouzo ^a   Deguchi, Masaaki ^a   Ogita, Sachio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Municipal Sumiyoshi Shimin Hospital   (Japan)

Author keywords

3 methylhistidine; Anemia inducing substance; Cancer cachexia; Myoblast; Plasma perfusion

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HEMOPERFUSION; MALE; MUSCLE ATROPHY; MYOBLAST; NONHUMAN; PERFUSION; PLASMA; PRIORITY JOURNAL; RABBIT; WEIGHT REDUCTION;

EID: 0031812713     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb03300.x     Document Type: Article

References (23)

1. Tisdale, M. J. Cancer cachexia. Anti-Cancer Drugs, 4, 115-125(1993).
2. Angíles, J. M., Garcia-Martínez, C., Llovera, M. and López-Soriano, F. J. The role of cytokines in muscle wasting: its relation with cancer cachexia. Med. Res. Rev., 12, 637-652(1992).
3. τ-Methylhistidine (3-methylhistidine) and muscle protein turnover: an overview. Fed. Proc., 37, 2291-2300 (1978).
4. Heber, D., Chlebowski, R. T., Ishibashi, D. E., Herrold, J. N. and Block, J. B. Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients. Cancer Res., 42, 4815-4819 (1982).
5. Lundholm, K., Bennegård, K., Edén, E., Svaninger, G., Emery, P. W. and Rennie, M. J. Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss. Cancer Res., 42, 4807-4811 (1982).
6. Ishiko, O., Deguchi, M., Tatsuta, I., Naka, K., Hirai, K., Nakata, S., Honda, K. and Sugawa, T. Removal of immunosuppressive substance in cancer patients' serum. Jpn. J. Cancer Res., 81, 564-566 (1990).
7. Deguchi, M., Ishiko, O., Hirai, K., Naka, K., Tatsuta, I. and Sugawa, T. Studies on pathogenesis of cancer cachexy -partial isolation of anemia-inducing substance (AIS) and basic study on removal of AIS by plasmapheresis. Adv. Obstet. Gynecol., 43, 128-137 (1991) (in Japanese).
8. Moss, F. P. and Leblond, C. P. Satellite cells as the source of nuclei in muscles of growing rats. Anat. Rec., 170, 421-436 (1971).
9. Carlson, B. M. The regeneration of skeletal muscle - a review. Am. J. Anat., 137, 119-150 (1974).
10. Tajima, Y. "Biological Reference Data Book on Experimental Animals," p. 96 (1989). Softscience Co., Ltd., Tokyo (in Japanese).
11. Kagawa, T., Chikata, E. and Tani, J. In vitro myogenesis of the mononucleate cells derived from regenerating muscles of adult mice. Dev. Biol., 55, 402-407 (1977).
12. Yaffe, D. Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc. Natl. Acad. Sci. USA, 61, 477-483 (1968).
13. Ono, T., Ohashi, M. and Yago, N. The effect of toxohormone on iron metabolism. Gann, 51, 213-221 (1960).
14. Fong, Y., Moldawer, L. L., Marano, M., Wei, H., Barber, A., Manogue, K., Tracey, K. J., Kuo, G., Fischman, D. A., Cerami, A. and Lowry, S. F. Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins. Am. J. Physiol., 256, R659-R665 (1989).
15. Lönnroth, C., Moldawer, L. L., Gelin, J., Kindblom, L., Sherry, B. and Lundholm, K. Tumor necrosis factor-α and interleukin-1α production in cachectic, tumor-bearing mice. Int. J. Cancer, 46, 889-896 (1990).
16. Ebisui, C., Tsujinaka, T., Morimoto, T., Kan, K., lijima, S., Yano, M., Kominami, E., Tanaka, K. and Monden, M. Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin. Sci., 89, 431-439 (1995).
17. Brouckaert, P., Spriggs, D. R., Demetri, G., Kufe, D. W. and Fiers, W. Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon γ. J. Exp. Med., 169, 2257-2262 (1989).
18. Balkwill, F., Osbornc, R., Burke, F., Naylor, S., Talbot, D., Durhin, H., Tavernier, J. and Fiers, W. Evidence for tumor necrosis factor/cachectin production in cancer. Lancet, ii, 1229-1232 (1987).
19. Nagabhushan, V. S. and Narasinga Rao, B. S. Studies on 3-methylhistidine metabolism in children with proteinenergy malnutrition. Am. J. Clin. Nutr., 31, 1322-1327 (1978).
20. Ishiko, O., Sugawa, T., Tatsuta, I., Shimura, K., Naka, K., Deguchi, M. and Umesaki, N. Anemia-inducing substance (AIS) in advanced cancer: inhibitory effect of AIS on the function of erythrocytes and immunocompetent cells. Jpn. J. Cancer Res. (Gann), 78, 596-606 (1987).
21. Tatsuta, I., Ishiko, O., Naka, K., Deguchi, M. and Sugawa, T. Studies on the pathogenesis of cancer anemia. Adv. Obstet. Gynecol., 41, 293-303 (1989) (in Japanese).
22. Naka, K., Ishiko, O., Tatsuta, I., Deguchi, M. and Sugawa, T. Studies on pathogenesis of cancer cachexy - production of AIS and its immunosuppressive effect. Adv. Obstet. Gynecol., 41, 305-312 (1989) (in Japanese).
23. Honda, K., Ishiko, O., Tatsuta, I., Deguchi, M., Hirai, K., Nakata, S., Sumi, T., Yasui, T. and Ogita, S. Anemia-inducing substance from plasma of patients with advanced malignant neoplasms. Cancer Res., 55, 3623-3628 (1995).